Greenlight Capital Re’s Innovations segment has reversed a US$12 million pre-tax loss from the first nine months of 2025 into a US$7.2 million profit over the same period this year, on gross premium growth running at nearly 10 times the pace of its core reinsurance book.
That shift sits at the center of Greenlight Re’s third-quarter results, which show the Cayman Islands-based reinsurer posting net income of US$3.2 million for the quarter, against a net loss of US$4.4 million in Q3 2025. The improvement came largely from a quieter catastrophe environment, which helped the group’s combined ratio settle at 90.5%, and from the innovations segment reversing a US$12 million pre-tax loss from the first nine months of 2025 into a US$7.2 million gain over the same period this year.
Get the latest reinsurance news direct to your inbox twice a week. Sign up here
The innovations segment, which Greenlight Re launched in 2018 to invest in and provide reinsurance capacity to early-stage MGAs and insurtech companies, wrote US$43 million in gross premiums in Q3 2026, up 46% from US$29 million in the same quarter of 2025. For the nine months to September 30, innovations gross premiums reached US$121.5 million, up 44% year-on-year from US$84.5 million. The segment now represents approximately 20% of total group gross premiums.
The year-ago loss was driven by a US$16.5 million impairment on a single investee in Q3 2025. The improvement in 2026 came primarily from net investment income of US$6 million in the quarter, generated by partial divestitures of two portfolio companies, partially offset by US$2.4 million in impairments on three others. Underwriting income also contributed, though the innovations combined ratio edged to 98.2% in Q3 2026 from 96.8% a year earlier, meaning the segment’s profit improvement is so far driven more by investment gains than by underwriting discipline alone.
The segment’s investment portfolio currently spans more than 40 active portfolio companies, with US$39.2 million in deployed capital. To manage the underwriting growth, Greenlight Re established a whole-account retrocession program in 2024, ceding a portion of innovations-related contracts to a panel of rated reinsurers. That arrangement provided third-party validation at scale and an override commission that partially offsets the segment’s overhead costs.
In late October, Greenlight Re announced a partnership with Hippo Holdings and its subsidiary Spinnaker Insurance Company, one of the stronger signals of where the innovations segment is heading. Under the arrangement, Hippo can invest alongside Greenlight Re in early-stage programs, while Spinnaker serves as the preferred US admitted fronting carrier for qualifying co-invested programs.
For emerging MGAs, the value is structural. Investment capital, admitted paper, and reinsurance capacity through a single aligned relationship rather than three separate negotiations. Spinnaker already fronts several programs that Greenlight Re has backed, so the partnership formalizes what was already a working relationship.
The group’s open market segment, which writes treaty reinsurance through broker channels and Lloyd’s, posted a combined ratio of 87.9% for Q3, with gross premiums of US$138.8 million, down from US$155 million in Q3 2025. The Q2 2026 results had flagged Middle East conflict reserves as a source of pressure. CEO Greg Richardson noted in the Q3 release that those reserves “developed favorably” in the quarter, suggesting the exposure is stabilizing.
Solasglas Investments, the hedge fund managed by chairman David Einhorn that holds approximately 70% of Greenlight Re’s investment assets, returned negative 3.3% in Q3, contributing a US$15.1 million loss to the quarter. For the nine months through September, Solasglas has contributed a US$9.3 million loss. Einhorn acknowledged the quarter was “challenging” for the portfolio.
Greenlight Re also announced that Joseph Platt will retire from the board effective December 31. Platt first joined the board at the company’s formation in 2004 and served as lead independent director from 2007. He stepped down in 2021 and rejoined in 2022, resuming the lead independent director role. His 27-year career was at Johnson & Higgins, the global insurance broker acquired by Marsh & McLennan in 1997. No successor has been named.
Get the latest reinsurance news direct to your inbox twice a week. Sign up here
